Trends in incidence and mortality of lung cancer in Huangpu District from 2002 to 2019
QIU Fengqian1, ZHAO Junfeng1, CHEN Weihua1, DU Juan1, JI Yunfang1, GAO Shuna1, MENG Jie2, HE Lihua1, CHEN Bo1, ZHANG Yan1
1. Huangpu District Center for Disease Control and Prevention (Huangpu District Health Supervision Institute), Shanghai 200023, China; 2. School of Medicine, Tongji University, Shanghai 200092, China
Abstract：Objective To investigate the trends in incidence and mortality of lung cancer in Huangpu District, Shanghai Municipality from 2002 to 2019, so as to provide the evidence for formulating lung cancer prevention and control measures. Methods Data of lung cancer incidence and mortality among residents in Huangpu District from 2002 to 2019 were collected through the Shanghai Cancer Registration and Reporting Management System. The crude incidence and mortality of lung cancer was calculated, and standardized by the data from the Chinese Fifth National Population Census in 2000 (Chinese-standardized rate) and the Segi's world standard population in 1960 (world-standardized rate). The trends in incidence and mortality of lung cancer among residents by age and gender were evaluated using annual percent change (APC). Results A total of 12 965 cases of lung cancer were reported in Huangpu District from 2002 to 2019, and the crude incidence rate was 80.66/105, the Chinese-standardized incidence rate was 34.54/105, and the world-standardized incidence rate was 31.30/105, all showing upward trends (APC=4.588%, 2.933% and 3.247%, all P<0.05). A total of 10 102 deaths of lung cancer were reported, and the crude mortality rate was 62.30/105, showing an upward trend (APC=0.959%, P<0.05); the Chinese-standardized mortality was 25.93/105, and the world-standardized mortality was 22.05/105, both showing downward trends (APC=-1.282% and -1.263%, both P<0.05). The crude incidence and mortality rates of lung cancer in males were higher than those in females (101.39/105 vs. 60.52/105, 85.45/105 vs. 39.87/105, both P<0.05). The crude incidence and mortality rates of lung cancer showed upward trends with age (both P<0.05), reaching their peaks in the age groups of 80-<85 years (341.37/105) and 85 years or above (355.97/105), respectively. Conclusions The incidence of lung cancer showed an upward trend, while the mortality showed a downward trend in Huangpu District from 2002 to 2019. Elderly men were the high-risk group for lung cancer incidence and mortality.
裘凤黔, 赵俊峰, 陈玮华, 杜娟, 纪云芳, 高淑娜, 蒙洁, 何丽华, 陈博, 张艳. 2002—2019年黄浦区肺癌发病和死亡趋势分析[J]. 预防医学, 2025, 37(2): 143-147.
QIU Fengqian, ZHAO Junfeng, CHEN Weihua, DU Juan, JI Yunfang, GAO Shuna, MENG Jie, HE Lihua, CHEN Bo, ZHANG Yan. Trends in incidence and mortality of lung cancer in Huangpu District from 2002 to 2019. Preventive Medicine, 2025, 37(2): 143-147.
[1] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249. [2] 张希,杨雷,刘硕,等.2022年全球恶性肿瘤统计报告解读[J].中华肿瘤杂志,2024,46(7):710-721. ZHANG X,YANG L,LIU S,et al.Interpretation of the 2022 global cancer statistics report[J].Chin J Oncol,2024,46(7):710-721.(in Chinese) [3] 郑荣寿,陈茹,韩冰峰,等.2022年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2024,46(3):221-231. ZHENG R S,CHEN R,HAN B F,et al.Cancer incidence and mortality in China,2022[J].Chin J Oncol,2024,46(3):221-231.(in Chinese) [4] 窦剑明,吴春晓,庞怡,等.2016年上海市肺癌发病和死亡的特征及其在2002—2016年的变化趋势[J].肿瘤,2023,43(4):266-276. DOU J M,WU C X,PANG Y,et al.The incidence and mortality of lung cancer in 2016 and their trends from 2002 to 2016 in Shanghai[J].Tumor,2023,43(4):266-276.(in Chinese) [5] 赫捷,魏文强.2019年中国肿瘤登记年报[M].北京:人民卫生出版社,2021. HE J,WEI W Q.2019 China cancer registry annual report[M].Beijing:People's Medical Publishing House,2021.(in Chinese) [6] 江雨琛,俞浩,罗鹏飞,等.1990—2019年江苏省肺癌疾病负担及其危险因素变化趋势研究[J].中国肿瘤,2022,31(5):327-334. JIANG Y C,YU H,LUO P F,et al.Trends of burden on lung cancer and related risk factors in Jiangsu Province from 1990 to 2019[J].China Cancer,2022,31(5):327-334.(in Chinese) [7] 石安霞,许慧琳,李为希,等.2013—2019年上海市闵行区肺癌流行特征趋势分析[J].中国肿瘤,2024,33(3):223-231. SHI A X,XU H L,LI W X,et al.Trend analysis on epidemiological characteristics of lung cancer in Minhang District of Shanghai from 2013 to 2019[J].China Cancer,2024,33(3):223-231.(in Chinese) [8] LIANG F,WU C X,GU H Y,et al.Lung cancer incidence in female rises significantly in urban sprawl of Shanghai after introduction of LDCT screening[J].Lung Cancer,2019,132:114-118. [9] 王春芳,郑莹,顾凯,等.城市地区癌症早发现工作的策略探讨[J].中国肿瘤,2010,19(2):93-96. WANG C F,ZHENG Y,GU K,et al.Stragety of early detection for cancer in urban area[J].China Cancer,2010,19(2):93-96.(in Chinese) [10] National Lung Screening Trial Research Team.Reduced lung-cancer mortality with low-dose computed tomographic screening[J].N Engl J Med,2011,365(5):395-409. [11] 李金,黄文,陈奇峰.2014—2019年绍兴市肺癌发病趋势分析[J].预防医学,2021,33(9):889-892. LI J,HUANG W,CHEN Q F.Trend of lung cancer incidence in Shaoxing from 2014 to 2019[J].China Prev Med J,2021,33(9):889-892.(in Chinese) [12] HILL W,LIM E L,WEEDEN C E,et al.Lung adenocarcinoma promotion by air pollutants[J].Nature,2023,616(7955):159-167. [13] 白勇,李萍,姜楠.肥胖、外周血血脂指标与非小细胞肺癌的孟德尔随机化研究[J].预防医学,2024,36(6):518-522. BAI Y,LI P,JIANG N.Associations of obesity and peripheral blood lipid indicators with non-small cell lung cancer:a Mendelian randomization study[J].China Prev Med J,2024,36(6):518-522.(in Chinese) [14] ORDÓÑEZ-MENA J M,SCHÖTTKER B,MONS U,et al.Quantification of the smoking-associated cancer risk with rate advancement periods:meta-analysis of individual participant data from cohorts of the CHANCES consortium[J].BMC Med,2016,14:1-15. [15] WU X M,ZHU B,ZHOU J,et al.The epidemiological trends in the burden of lung cancer attributable to PM2.5 exposure in China[J].BMC Public Health,2021,21(1):1-8. [16] ZHENG R S,ZHANG S W,ZENG H M,et al.Cancer incidence and mortality in China 2016[J].J Natl Cancer Cent,2022,2(1):1-9. [17] 项彩英,汪德兵.2011—2022年开化县肺癌发病和死亡趋势分析[J].预防医学,2023,35(10):885-889. XIANG C Y,WANG D B.Trends in incidence and mortality of lung cancer in Kaihua County from 2011 to 2022[J].China Prev Med J,2023,35(10):885-889.(in Chinese)
